James Wassil
Directeur des opérations chez VAXCYTE, INC.
Fortune : 15 M $ au 31/05/2024
Postes actifs de James Wassil
| Sociétés | Poste | Début | Fin |
|---|---|---|---|
| VAXCYTE, INC. | Directeur des opérations | 01/12/2019 | - |
Historique de carrière de James Wassil
Anciens postes connus de James Wassil
| Sociétés | Poste | Début | Fin |
|---|---|---|---|
| ICOSAVAX, INC. | Directeur/Membre du Conseil | 01/06/2022 | 19/02/2024 |
| Independent Dir/Board Member | 01/06/2022 | 19/02/2024 | |
| PFIZER, INC. | Corporate Officer/Principal | 01/05/2015 | 01/12/2019 |
| NOVARTIS AG | Corporate Officer/Principal | 01/08/2008 | 01/05/2015 |
Infectious Diseases Society of America
 Infectious Diseases Society of America Miscellaneous Commercial ServicesCommercial Services The Infectious Diseases Society of America is a non-profit company that provides clinical practice guidelines development and guideline panelists for infectious diseases. The company is based in Arlington, VA and has subsidiaries in the United States. The company specializes in antimicrobial stewardship and have established Antimicrobial Stewardship Centers of Excellence. The CEO of the company is Christopher Busky. | Corporate Officer/Principal | - | - |
| MERCK & CO., INC. | Sales & Marketing | - | - |
Formation de James Wassil
| University of Notre Dame | Undergraduate Degree |
| Lehigh University | Graduate Degree |
Statistiques
Internationale
| Etats-Unis | 8 |
| Suisse | 2 |
Opérationnelle
| Corporate Officer/Principal | 3 |
| Chief Operating Officer | 1 |
| Sales & Marketing | 1 |
Sectorielle
| Health Technology | 6 |
| Consumer Services | 3 |
| Commercial Services | 2 |
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Sociétés liées
| Sociétés cotées | 4 |
|---|---|
| VAXCYTE, INC. | Health Technology |
| PFIZER, INC. | Health Technology |
| NOVARTIS AG | Health Technology |
| MERCK & CO., INC. | Health Technology |
| Entreprise privées | 2 |
|---|---|
Infectious Diseases Society of America
Infectious Diseases Society of America Miscellaneous Commercial ServicesCommercial Services The Infectious Diseases Society of America is a non-profit company that provides clinical practice guidelines development and guideline panelists for infectious diseases. The company is based in Arlington, VA and has subsidiaries in the United States. The company specializes in antimicrobial stewardship and have established Antimicrobial Stewardship Centers of Excellence. The CEO of the company is Christopher Busky. | Commercial Services |
Icosavax, Inc.
 Icosavax, Inc. Pharmaceuticals: MajorHealth Technology Icosavax, Inc. engages in the development and commercialization of vaccines against infectious diseases. It focuses on developing vaccine candidates for viral causes of pneumonia in older adults. The company was founded by Neil King and David Baker on November 1, 2017 and is headquartered in Seattle, WA. | Health Technology |
- Bourse
- Insiders
- James Wassil
- Expérience
